P-VBI Improves Clinical Outcomes, Key Metric Performance and Markedly Reduces Annual Rx Expenditures Leading to Enhanced Performance Based Incentive Payments.
The Pharmazam Value Based Incentive Program (P-VBI) assists the HCP in improving patient care and cost savings. Pharmazam addresses the issue of empiric prescribing by eliminating suboptimal prescriptions that don’t work, that prolong and/or create additional treatment costs or lead to an adverse drug reaction resulting in hospitalization and/or re-admission (penalty) or an untoward event. Pharmazam enables health care providers to prescribe/dispense the right medication the first time. This in turn improves clinical outcomes, related metric performance, drives savings and positions the HCP for a significant performance based incentive.
The main structural flaw of the federal pay-for-performance approach is that it does not involve patients in the drive for better value. Pharmazam ties the patient into the execution and delivery of better, quality and more affordable care. Affordable health care is possible when the entire delivery system, which includes payers, care providers, and patients, is more accountable for cost, quality and experience and this is accomplished by utilizing the Pharmazam System.
Pharmazam also analyzes the entire patient population 24/7 and automatically notifies the payer organization about potential severe Critical Events that could be caused by medication issues prior to an event happening. This pre-notification prior to a critical event will help save lives, increase the overall quality of health for the entire patient population, and save an enormous amount of money for all associated parties.